SCHEMBL453564

SCHEMBL453564

O[N]Cc1ccccc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1653 0.78 ALDH1A1 (0.55)
Hydrogen Sulfide SCHEMBL5079696 0.75 ALDH1A1 (0.52)
SCHEMBL17178869 0.75 ALDH1A1 (0.52)
SCHEMBL19611522 0.75 ALDH1A1 (0.52)
SCHEMBL15506263 0.75 ALDH1A1 (0.52)
SCHEMBL5370459 0.72 TDP1 (0.52)
SCHEMBL622351 0.71
SCHEMBL4870227 0.71
SCHEMBL1506483 0.71
SCHEMBL774900 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 92 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-106470973-A Small molecule lfa-1 inhibitors 阿罗赛特制药公司 2017-03-01 CN claimed
WO-2015181799-A1 COMPOUNDS AND METHODS FOR TREATING TUBERCULOSIS FOUNDATION FOR NEGLECTED DISEASE RESEARCH (IN) 2015-12-03 WO claimed
EP-1021186-A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha CV THERAPEUTICS, INC. (US) 2000-07-26 EP claimed
EP-1021186-A4 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IkappaB-alpha CV THERAPEUTICS INC (US) 2000-07-26 EP claimed
WO-1998005335-A9 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IλB-$g(a) 1998-05-28 WO claimed
WO-1998005335-A1 PURINE INHIBITORS OF CYCLIN DEPENDENT KINASE 2 AND IλB-$g(a) CV THERAPEUTICS, INC. (US) 1998-02-12 WO claimed
US-5387266-A Detergent-dispersant additives for fuels and lubricants ETHYL CORPORATION (US) 1995-02-07 US claimed
US-4617401-A ANTISPASMODIC AGENTS, VASODILATORS SUNTORY LTD. (JP) 1986-10-14 US claimed
US-4448715-A Tagged pyroglu-L-Phe-L-Arg derivatives, substrates and assays for kallikrein UNIVERSITY OF MIAMI (US) 1984-05-15 US claimed
EP-0078703-A2 New tagged pyroglu-l-phe-l-arg derivatives, substrates and assays for kallikrein UNIVERSITY OF MIAMI (US) 1983-05-11 EP claimed
EP-2516399-B1 PHENOLIC DERIVATIVES AND PHARMACEUTICAL OR COSMETIC USE THEREOF GALDERMA RES & DEV (FR) 2018-04-18 EP disclosed
EP-2516398-B1 PHENOLIC DERIVATIVES, AND THEIR PHARMACEUTICAL OR COSMETIC USE GALDERMA RES & DEV (FR) 2018-03-21 EP disclosed
CN-106470973-A Small molecule lfa-1 inhibitors 阿罗赛特制药公司 2017-03-01 CN disclosed
WO-2015181799-A1 COMPOUNDS AND METHODS FOR TREATING TUBERCULOSIS FOUNDATION FOR NEGLECTED DISEASE RESEARCH (IN) 2015-12-03 WO disclosed
WO-2015181799-A1 COMPOUNDS AND METHODS FOR TREATING TUBERCULOSIS FOUNDATION FOR NEGLECTED DISEASE RESEARCH (IN) 2015-12-03 WO disclosed
EP-0122321-A1 Hydroxybenzylamino derivatives as anti-inflammatory agents MERCK & CO. INC. (US) 1984-10-24 EP disclosed
EP-0122321-A1 Hydroxybenzylamino derivatives as anti-inflammatory agents MERCK & CO. INC. (US) 1984-10-24 EP disclosed
US-4448715-A Tagged pyroglu-L-Phe-L-Arg derivatives, substrates and assays for kallikrein UNIVERSITY OF MIAMI (US) 1984-05-15 US disclosed
EP-0081782-A1 Hydroxybenzylamino-aryl compounds, process for preparing and pharmaceutical compositions containing the same MERCK & CO. INC. (US) 1983-06-22 EP disclosed
EP-0078703-A2 New tagged pyroglu-l-phe-l-arg derivatives, substrates and assays for kallikrein UNIVERSITY OF MIAMI (US) 1983-05-11 EP disclosed